Songwriting to Reduce Anxiety in Teens with Sickle Cell Disease
Official title: Writing Relaxing Beats in Adolescents Who Have Sickle Cell Disease
Run by Mayo Clinic · NCT07222475 · Data updated 2026-11-12
This program will try songwriting and performing original songs to see if it helps reduce anxiety in adolescents (ages 11–18) with sickle cell disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 11 Years to 18 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | February 5, 2026 |
| Main results expected | July 31, 2026 |
| Study ends | July 31, 2026 |
| Registry record updated | February 23, 2026 |
| Trial ID | NCT07222475 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adolescents aged 11–18 with any type of sickle cell disease who are receiving care at a pediatric center, can read and write English, and can provide assent.
✕Probably not a fit
Patients who have transitioned to adult care or who have visual, hearing, or cognitive impairments that prevent completing songwriting activities or study measures may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional program offers adolescents with sickle cell disease guided songwriting sessions as an active music therapy approach that combines composition, performance, and relaxation techniques. Participants will create and play their own songs while researchers collect feedback on practicality and acceptability. Standardized self-report anxiety measures and feasibility questionnaires will be administered before and after the intervention to track changes and usability. The work is conducted in a pediatric setting at the Mayo Clinic and targets English-literate teens who can provide assent.
Why it matters
Potential benefit: If successful, this approach could give teens a low-cost, creative tool to lower anxiety and improve coping with sickle cell disease and its symptoms.
How similar studies have gone: Music therapy has shown benefits for anxiety and pain in pediatric and adult populations, but songwriting as a structured intervention in adolescents with sickle cell disease is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adolescents aged 11-18 years of age at the time of enrollment and able to provide assent * Diagnosed with any type of sickle cell disease * Currently receiving care at pediatric center * Able to read and write in English Exclusion Criteria: * Care transitioned to adult facility * Visual, hearing, or cognitive impairment which may impede the ability to complete the songwriting intervention or data collection measures
Where it's running
-
Mayo Clinic Division of Nursing
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: C. Robert Bennett, PhD — Mayo Clinic
- Study coordinator: Pam Peterson
- Email: Peterson.Pamela@Mayo.edu
- Phone: 507-422-5523
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cerebrovascular Reactivity Testing with HD-DOT in Sickle Cell Patients
This study tests whether high-density diffuse optical tomography can measure brain blood flow and oxygen use in people with sickle cell disease, to see how these signals relate to stroke risk.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Newborn Sickle Cell Screening in Mozambique
We’re testing a three-part plan to help babies in Mozambique get diagnosed early for sickle cell disease and start care quickly.
-
Optimizing Hydroxyurea in Children with Sickle Cell in Africa
This study tests whether raising hydroxyurea to a maximum tolerated dose is safe and beneficial for Ugandan children with sickle cell anemia already taking a fixed daily dose.
-
Hematopoietic stem cell editing to treat sickle cell disease
This study tests whether a patient’s own blood stem cells can be edited to remove the sickle cell triggering gene and then returned to the patient.
-
Virtual reality options to help with VOC pain in adults with SCD
This study tests whether headset-based virtual reality can help reduce pain for adults with sickle cell disease during vaso-occlusive crises treated in an infusion center.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.